# Mini-Allogeneic Peripheral Blood Progenitor Cell Transplantation For Recurrent or Metastatic Breast Cancer

> **NCT00429572** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 19 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Fludarabine
- **DRUG:** Melphalan
- **PROCEDURE:** Stem Cell Infusion

## Key facts

- **NCT ID:** NCT00429572
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-01
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2012-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00429572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00429572, "Mini-Allogeneic Peripheral Blood Progenitor Cell Transplantation For Recurrent or Metastatic Breast Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00429572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*